• Home
  • Stages
    • Late Discovery
    • Early Development
    • Late Development & Commercialization
    • Lifecycle Management
  • Services
    • Project Leadership & Business Solutions
    • Late Discovery & Investigative Research
    • Chemistry, Manufacturing & Controls (API & Drug Product)
    • Nonclinical Sciences
    • Clinical Strategy
    • Regulatory Strategy & Application Preparation
    • Quality & Compliance
    • Advanced Technologies
  • Leadership
  • News
  • Careers
  • Contact
  • Home
  • Stages
    • Late Discovery
    • Early Development
    • Late Development & Commercialization
    • Lifecycle Management
  • Services
    • Project Leadership & Business Solutions
    • Late Discovery & Investigative Research
    • Chemistry, Manufacturing & Controls (API & Drug Product)
    • Nonclinical Sciences
    • Clinical Strategy
    • Regulatory Strategy & Application Preparation
    • Quality & Compliance
    • Advanced Technologies
  • Leadership
  • News
  • Careers
  • Contact

 

Michael Neeb, PhD — VP Pre-Clinical & Business Development

Michael Neeb, PhD, VP Pre-Clinical & Business DevelopmentMike is a pharmaceutical industry veteran with 22 years of experience in research, alliance and program management, business development, scientific diligence, contract management and business projects. 

Mike began his career in medicinal chemistry at SmithKline Beecham (now GSK), delivering multiple candidate and pre-candidate molecules as a team and matrix leader.  He then transitioned to its innovative Center of Excellence for External Drug Discovery where he helped to set strategy leading to the creation of complex alliances in the biotech space.  Mike variably also served as the alliance leader or joint steering committee member for established alliances and focused his efforts primarily at the interface of discovery and development.  Subsequently, he held a similar role in GSK’s ophthalmology research unit before joining Johnson & Johnson Diabetes, leading multi-disciplinary teams in the evaluation and execution of business relationships.

Mike is a strategic and scientific thinker, highly skilled at drug discovery, preclinical development, and managing teams and business relationships, and has led programs across therapy areas including in oncology, cardiovascular disease, inflammatory disorders, infectious diseases and ophthalmology. 

Expertise:

  • Leading teams in Drug Discovery and Preclinical Development
  • Driving structure activity relationships and developability characteristics in medicinal chemistry
  • Development and leadership of cross-organizational relationships


  • [email protected]

  • Terms of Use
  • Privacy Policy
  • Copyright Policy
  • 2023 © Copyright NGT BioPharma Consultants

860.333.9023 · [email protected]